NUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million

Bulletin Express

Mar 04

Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.

XtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.

NUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1176580709"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176580709\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176580709?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176580709","market":"us","top_or_hot":-1,"title":"NUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million","media":"Bulletin Express","content":"<p>Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.</p>\n<p>XtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.</p>\n<p>NUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-04 19:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.</p>\n<p>XtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.</p>\n<p>NUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02530","symbol_name":"纽曼思","start_time":0,"source_url":"","article_id":"1176580709","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176580709","pubTimestamp":1772623337,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02530":"纽曼思"},"translate_title":"纽曼斯(02530)宣布收购价值1973万港元XtalPi股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02530":1},"content_text":"Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.\nXtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.\nNUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}